The Canadian Clinical Research Initiative: transforming Canadian clinical research capacity

Cairns, John A.
December 2004
Clinical & Investigative Medicine;Dec2004, Vol. 27 Issue 6, p292
Academic Journal
The editor, in this article, discusses Canadian clinical research initiative. Clinical research combines the discoveries from the basic science laboratory with the observations and insights of clinicians. Potential therapeutic as well as diagnostic and preventive measures are tested in pre-clinical settings and, as appropriate, go forward to rigorous evaluation in humans. Recognition of the need to enhance Canadian capacity to conduct clinical research and the associated opportunity for international leadership have prompted the Canadian Institutes of Health Research to establish an initiative to strengthen clinical research in this country.


Related Articles

  • Improving Topical Microbicide Applicators for Use in Resource-Poor Settings. Vail, Janet G.; Cohen, Jessica A.; Kelly, Kimberly L. // American Journal of Public Health;Jul2004, Vol. 94 Issue 7, p1089 

    With more than 60 potential microbicides being assessed in preclinical or clinical trials, most attention has been centered on products intended for topical application, with much less research conducted on the applicators that will be used to deliver the microbicides. However, applicator design...

  • Should healthy volunteers in clinical trials be paid according to risk? Jones, Eleri; Liddell, Kathleen; Saunders, John // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/16/2010, Vol. 340 Issue 7738, p130 

    The authors claim that healthy volunteers in clinical trials should be paid according to risk. They pointed out that the action of volunteers is a gift to the society due to the higher risks in some clinical trials. They also think that this kind of voluntarism is inconsistent with other...

  • EDC Acceptance in Japan. Brock, Andy; McNulty, Kevin; Summer, Maria // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p56 

    The article reports on the use of electronic data capture (EDC) in clinical trials in Japan. It cites that the country was once lagging behind its regional competitors in the Asia-Pacific drug development market, but with its use of the EDC, it has become a force in the region in terms of drug...

  • YKL-40--A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Schultz, Nicolai A.; Johansen, Julia S. // Cancers;2010, Vol. 2 Issue 3, p1453 

    YKL-40 is a 40 kDa glycoprotein produced by cancer cells, inflammatory cells and stem cells. It probably has a role in cell proliferation and differentiation, inflammation, protection against apoptosis, stimulation of angiogenesis, and regulation of extracellular tissue remodelling. Plasma...

  • The Case for Universal GCP Education. Green, Jeanne // Applied Clinical Trials;Dec2012, Vol. 21 Issue 12, p14 

    The article presents information about Good Clinical Practice (GCP) which is considered as an international, ethical and scientific quality standard for conducting the clinical trials for humans. It mentions that main aim of GCP is to protect the safety, rights, and welfare of subjects and...

  • Translational research: 4 ways to fix the clinical trial. Ledford, Heidi // Nature;9/29/2011, Vol. 477 Issue 7366, p526 

    The article discusses the ways to save clinical trials as they are crumbling under economic and scientific pressures. Researchers and patient advocates take a page from organizations to make it easier to find eligible volunteers. Early tests dubbed phase 0 studies are conducted to show how a...

  • Laboratory quality control in the National Cooperative Dialysis Study. Frankel, Rita; Engel, Robert H.; Olivier, Donald C.; Halpern, E. Philip // Kidney International Supplement;Apr1983, Issue 13, pS-31 

    Focuses on the quality-control program for the participating laboratories of the U.S. National Cooperative Dialysis Study. Performance of biochemical tests; Use of clinical facility; Testing methods used by laboratories.

  • Can the New Humanized Mouse Model Give HIV Research a Boost. Shacklett, Barbara L. // PLoS Medicine;Jan2008, Vol. 5 Issue 1, pe13 

    The "BLT mouse" holds promise for the preclinical evaluation of microbicides and antiretroviral prophylaxis regimens.

  • Serious adverse events in academic critical care research. Cook, Deborah; Lauzier, Fran├žois; Rocha, Marcelo G.; Sayles, Mary Jane; Finfer, Simon // CMAJ: Canadian Medical Association Journal;4/22/2008, Vol. 178 Issue 9, p1181 

    The article discusses proposed solutions for more rational reporting of serious adverse events in academic critical care trials of drugs in common use. According to the authors, investigators must clearly describe the serious adverse events that they plan to identify and report in their protocol...

  • They're Dying to Get In. Bjerklie, David // Time;4/22/2002, Vol. 159 Issue 16, p56 

    Discusses the difficulty of being able to participate in clinical trials in medicine. Benefits of the trials, including substantial doctor-patient interaction; Idea that it is not just the terminally ill who benefit from the attention, but also medically neglected or poorly informed subjects...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics